Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04332471 · ClinicalTrials.gov registry record · NA
Shockwave Therapy for Plantar Fasciitis RCT
A NA study of Plantar Fascitis, sponsored by Hospital for Special Surgery, New York.
- Active
- Registry status
- NA
- Development phase
- 114
- Enrollment target
- 1
- Study location
NCT04332471: Active NA study of Plantar Fascitis, sponsored by Hospital for Special Surgery, New York.
NCT04332471 is a NA study of Plantar Fascitis that is active but no longer recruiting, run by Hospital for Special Surgery, New York. The registered enrollment target is 114 participants, above the 79-participant average among 7 other Plantar Fascitis trials with a reported enrollment target (44% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04332471, a NA study of Plantar Fascitis, is active but no longer recruiting, sponsored by Hospital for Special Surgery, New York.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
- 1
- Study location
Study Summary
Inflammation of the plantar fascia is known as plantar fasciitis and is commonly seen in active or overweight individuals. It can be treated via conservative or surgical therapies. Extracorporeal shockwave therapy has shown promise in the treatment of plantar fasciitis. Several studies have compared the effects of different types of extracorporeal shockwave therapy (radial and focused) with other forms of conservative treatment in patients with chronic plantar fasciitis. No study has yet compared the effect of radial vs. focused shockwave therapy on pain in this population.
Primary Outcome
Morning pain. This will be assessed on a scale of 0-100, with a higher score representing more pain.
Conditions Studied
Interventions
- PROCEDURE Radial shockwave therapy
- PROCEDURE Focused shockwave therapy
- DEVICE Shockwave therapy device
- OTHER Home therapy
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
What the registry record for NCT04332471 still lists
NCT04332471 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, above the 79-participant average among 7 other Plantar Fascitis trials with a reported enrollment target (44% higher).
The record links to 1 condition, with Plantar Fascitis appearing as the primary indexed condition, and to 4 interventions - of which Radial shockwave therapy is the first listed.
NCT04332471 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04332471 about?
NCT04332471 is a clinical study titled "Shockwave Therapy for Plantar Fasciitis RCT". Inflammation of the plantar fascia is known as plantar fasciitis and is commonly seen in active or overweight individuals. It can be treated via conservative or surgical therapies. Extracorporeal shockwave therapy has shown promise in the treatment of plantar fasciitis. Several studies have compared...
What is the current status of trial NCT04332471?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 114 participants. The study started on 2020-06-01. Estimated completion is 2026-03-01.
What conditions does trial NCT04332471 study?
This clinical trial studies the following conditions: Plantar Fascitis.
What interventions are being tested in trial NCT04332471?
The interventions under investigation include: Radial shockwave therapy (PROCEDURE), Focused shockwave therapy (PROCEDURE), Shockwave therapy device (DEVICE), Home therapy (OTHER).
Who is sponsoring clinical trial NCT04332471?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04332471 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plantar Fascitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dynamic Versus Static Night Splinting of Plantar Fasciitis
RECRUITING · NA
-
Plantar Fasciitis Randomized Clinical Control Trial
RECRUITING · NA
-
HP Arize 3D Orthotics for Planar Fasciitis
ACTIVE NOT RECRUITING · NA
-
Effects of Foot Rehabilitation And Minimalist Shoes on Pain, Strength, and Function in Adults With Plantar Fasciopathy
COMPLETED · NA
-
Effects of Exercise Versus Exercise and Instrument-Assisted Soft Tissue Mobilization for Plantar Fasciopathy Treatment
COMPLETED · NA
-
Acupuncture for Plantar Fasciosis in the Primary Care Setting
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI